Monoclonal Antibodies: US$ 34 Billion Approach to Cancer PR-BG.com (прессъобщения) (press release) The past few years have witnessed the emergence of monoclonal antibodies as therapeutic modality for cancer. Monoclonal antibodies are designed to selectively target cancer cells and elicit various responses thereby obliquely protecting the non ... |
